New eye injection aims to halt blinding disease
Disease control
Ongoing
This study is testing a new drug called AVD-104, given as an injection into the eye, for people with geographic atrophy (GA), a severe form of age-related macular degeneration that causes progressive vision loss. The main goal is to see if the drug is safe and if it can slow down…
Phase: PHASE2 • Sponsor: Aviceda Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC